• Fosfomycin sodium packaged and labeled.

click on thumbnail to zoom
SKU: F013

Size  
Quantity:
  Click 'Bulk Order' for 10 or more
Price: make selection(s)
Description

Fosfomycin Sodium is broad-spectrum phosphoenolpyruvate analog antibiotic.  It has a chemically unique structure unlike any other antibacterial agent.  Fosfomycin has been found to have an immunomodulatory effect on human B-cell activation.  Fosfomycin Sodium is freely soluble in aqueous solution.

    CAS Number

    26016-99-9

    Molecular Formula

    C3H5Na2O4P

    Molecular Weight

    182.02

    Mechanism of Action

    Fosfomycin prevents peptidoglycan synthesis by inhibiting MurA, an enzyme responsible for synthesizing N-acetylmuramic acid, a major component of peptidoglycan.  The compound also inactivates the bacterial enzyme N-acetylglucosamine-3-o-enolpyruvyl transferase, which is essential for the synthesis of bacterial wall peptidoglycan.

    Fosfomycin has been found to have immunosuppressive activity, which is not linked to its bactericidal activity, since the enantiomer of Fosfomycin does not have antimicrobial activity.  Rather, the immunosuppressive action is seen by its immunomodulatory effect on human B-cell activation. 

    Storage Conditions

    2-8°C

    Tariff Code

    2941.90.5000

    Spectrum

    Fosfomycin sodium is a broad spectrum antibiotic frequently used to treat bacterial infections of the urinary tract. Fosfomycin has been found to be effective against certain β-lactam resistant strains of VRE or vancomycin resistant Enterococcus; a glycopeptide antibiotic resistant "superbug."

Applications

    Eukaryotic Cell Culture Applications

    Investigators examined the effect of Fosfomycin on the immune system, specifically the in vitro function of human T cells, and was found to exert its action on the late stage of T-cell activation.  It inhibited the proliferation of human lymphocytes induced by polyclonal T-cell mitogens.  It suppressed mixed lymphocyte reaction and the production of interleukin-2 by T-cells.  Fosfomycin also inhibited the expression of IL-2 receptor and transferrin receptor on T-cell surfaces.   This property widens the therapeutic indices as it could be combined with immunosuppressants in organ transplantation (Morikawa et al, 1993).

    Microbiology Applications

    Fosfomycin sodium is commonly used in clinical in vitro microbiological antimicrobial susceptibility tests (panels, discs, and MIC strips) against Gram-positive and Gram-negative microbial isolates.  Medical microbiologists use AST results to recommend antibiotic treatment options for infected patients.  Representative MIC values include:

    • Escherichia coli 0.19 µg/mL – 64 µg/mL
    • Helicobacter pylori 0.05 µg/mL – 12.5 µg/mL
    • For a complete list of Fosfomycin Sodium MIC values, click here.

    Media Supplements

    Fostfomycin can be used as a selective agent in several types of isolation media:

    Listeria Selective Agar - Listeria Selective Supplement

    Listeria Selective Agar - Modified Listeria Selective Supplement

    Fosfomycin Sodium can be used for bacterial infections of the urinary tract. Fosfomycin has been found to be effective against certain β-lactam resistant strains of VRE or vancomycin resistant Enterococcus; a glycopeptide antibiotic resistant "superbug."

Specifications

    Form

    Powder

    Appearance

    White or off-white powder

    Source

    Streptomyces spp.

    Impurity Profile

    Heavy Metals: ≤20ppm
    1,2 Dihydroxyl-propylphosphonate: ≤1.0%

    Water Content (Karl Fischer)

    ≤1.0%

    pH

    9.0-10.5

    Melting Point

    >300°C

    Optical Rotation

    -13° to -15°

    Assay

    (On Dried Basis): 95.0-101.0%

References

    References

    Baum EZ et al (2001)  Identification and characterization of new inhibitors of the Escherichia coli MurA enzyme. Antimicrob. Agents Chermother. 45(11):3182-3188  PMID 11600375

     Falagas ME and Kastaris AC (2010)  Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: A systematic review.   Lancet Infect. Dis. 10(1): 43-50 PMID 20129148

    Morikawa K,  Oseko F, Morikawa S, Sawada M(1993)  Immunosuppressive activity of fosfomycin on human T-lymphocyte function in vitro.  Antimicrob. Agents Chemother. 37(12): 2684-2687  PMID 7509146

Other Items In This Category